14.3 CMEA and Behind-the-Counter Products

Why CMEA still appears on a state jurisprudence exam

Quick Answer: The Combat Methamphetamine Epidemic Act of 2005 (CMEA) (Title VII of P.L. 109-177; 21 U.S.C. § 830; 21 CFR Part 1314) puts ephedrine, pseudoephedrine, and phenylpropanolamine nonprescription products behind the counter as scheduled listed chemical products (SLCPs). Retail limit: 3.6 g of base per purchaser per day, regardless of transactions, and 9 g of base in 30 days. Mail-order (and mobile vendors): 7.5 g / 30 days. Photo ID, a logbook (except a single sales package ≤60 mg of pseudoephedrine), behind-the-counter or locked placement, blister packs, employee training, and DEA self-certification. Connecticut has not published a stricter retail gram cap or Rx-only status.

NABP Competency 3.8 covers nonprescription and restricted OTC products. Pseudoephedrine is not a CSA schedule in this lane. It is a List I chemical in a nonprescription dosage form. Confusing it with Schedule V codeine cough syrup (CGS § 21a-272) is how candidates pick the wrong logbook.

Phenylpropanolamine was withdrawn from human OTC use by FDA; remaining PPA is essentially veterinary prescription. The exam’s retail math is pseudoephedrine and, less often, ephedrine.

The gram clocks — daily, monthly, mail

Limits are in base, not tablet weight. A 30 mg pseudoephedrine HCl tablet is not 30 mg of base. DEA’s informational chart (not itself a regulation, but the chart DCP and DEA training still use) is the practical conversion:

A customer who already bought 120 tablets of 30 mg pseudoephedrine HCl this morning cannot pick up another box of 30 at 4 p.m. even at a second store the pharmacist happens to own — the daily 3.6 g is per purchaser, not per NDC and not per cash-register. Selling a 96-count box of 120 mg extended-release (DEA chart: 36 tablets = 3.6 g) as a “one-box” convenience still hits the daily ceiling if the patient already bought Sudafed at 8 a.m.

Mail-order is the trap for a Connecticut nonresident pharmacy shipping into the state: 7.5 g / 30 days, plus identity confirmation before shipping. Do not apply the 9 g retail number to a UPS carton.

Nonliquid forms, including gelcaps, must be in two-unit blister packs unless a blister is not technically feasible, in which case unit-dose packets or pouches are allowed.

Behind the counter, ID, logbook, and the 60 mg exception

Placement is physical, not a policy binder:

• A regulated seller (pharmacy, grocery, general merchandise) must keep SLCPs where customers do not have direct access before the sale — behind the counter — or in a locked cabinet even if that cabinet is on the sales floor. The seller delivers the product into the purchaser’s custody.
• A mobile retail vendor must use a locked cabinet and is capped at the 7.5 g / 30-day figure.

Before the sale (except the 60 mg single-package carve-out):

• The purchaser presents a photographic identification card issued by a State or the Federal Government, or another document acceptable under 8 CFR § 274a.2(b)(1)(v)(A) or (B).
• The logbook (written or electronic) identifies product name, quantity sold, purchaser name and address, and date and time. The purchaser signs and enters name, address, and date/time. The seller confirms the name matches the ID and that the date and time are correct, then enters product and quantity.
• The logbook must display the 18 U.S.C. § 1001 false-statement warning, including the maximum $250,000 fine and 5 years imprisonment.
• Keep each entry not fewer than two years after the date it is made. Good-faith release of logbook information to law enforcement is generally immunized unless the release is gross negligence or intentional misconduct.

The logbook requirement does not apply to any purchase by an individual of a single sales package that contains not more than 60 mg of pseudoephedrine. Two 30 mg tablets in one blister card is the classic carton. That exception is still in the federal text; it is not a free pass around the 3.6 g daily cap if the patient returns for twenty “60 mg” packages. ID/logbook drop away for that one small package; the daily gram math does not.

Self-certification to the Attorney General is required for each place of business. Employees who hand the product to the purchaser or take payment must complete seller-provided training. Selling without a current self-certification is a CMEA violation even if the logbook is perfect.

Connecticut overlay — do not invent one

DCP has posted federal anti-meth training for pharmacies. Some states made pseudoephedrine prescription-only or mandated NPLEx real-time stops. Connecticut has not published a stricter retail gram number, an Rx-only switch, or a statute that replaces CMEA’s 60 mg logbook exception. On this exam, federal CMEA is the Connecticut retail rule unless the stem quotes a later DCP bulletin. A chain that uses NPLEx is following store/policy and federal tools, not a CGS gram cap.

Keep Schedule V exempt preparations (CGS § 21a-272 — limited quantities of listed opium-containing cough mixtures, purchaser handwriting, 48-hour quantity cap) in a different mental bin. Those are controlled-substance exceptions with a CV record. Pseudoephedrine is a listed chemical with a CMEA logbook. One binder, two statutes, two quantity math problems.

Realistic Connecticut scenario

A Hartford customer wants two 24-count boxes of 30 mg pseudoephedrine HCl (48 tablets) at 10 a.m. and already bought a 24-count box at 8 a.m. elsewhere. Forty-eight plus 24 is 72 tablets — still under 146, so the daily 3.6 g is intact if the morning purchase is known. Without a logbook look, the pharmacist cannot see the 8 a.m. store. That is why the logbook (and any NPLEx the chain uses) exists. The product comes from behind the counter, ID is photocopied into the workflow, the patient signs, and the record is kept two years.

The same patient asks for a mail-order 90-count of 30 mg tablets. 7.5 g / 30 days is 305 of those tablets, so 90 is under the mail cap if nothing else shipped this month — and the seller must confirm identity before shipping. A 60 mg single-package “trial” card sold at the register does not need a logbook line; selling twelve of those cards to dodge the logbook still counts toward 3.6 g.

Official anchors

• DEA CMEA general information — 3.6 g / 9 g / 7.5 g, blister packs, behind-the-counter, logbook, 60 mg exception, ID, two-year retention, self-certification.
• 21 U.S.C. § 830 — scheduled listed chemical sales quantity and logbook.
• 21 CFR Part 1314 — retail sale of scheduled listed chemical products.
• DCP anti-meth federal summary — DCP pointing pharmacies at federal CMEA, including the 60 mg logbook exception.